Dr Thomas Bachelot
- Spécialité
- Oncologue médical, expert sein et gynécologie
- Titre
- Coordinateur adjoint de département
- Hôpital
- Centre Léon Bérard (Lyon)
- Derniers articles
-
- Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulation. (1 déc. 2024)
- Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. (1 déc. 2024)
- Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer. (17 nov. 2024)
- Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors. (1 oct. 2024)
- Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial. (1 août 2024)